ライフサイエンスコーパス: neonatal intensive care

1 Opioid analgesia is commonly used during neonatal intensive care.

2 a risk-adjustment instrument widely used in neonatal intensive care.

3 bers of survivors of high-risk obstetric and neonatal intensive care.

4 d to stressful and painful procedures during neonatal intensive care.

5 0.51, 95% CI 0.28 to 0.90; p=0.0210), fewer neonatal intensive care admissions lasting more than 24

6 stroschisis have paralleled advances made in neonatal intensive care and the use of parenteral nutrit

7 s variability as requests for resuscitation, neonatal intensive care, and surgical intervention are b

8 Level and volume of neonatal intensive care at the hospital of birth.

9 no consistent relation between the number of neonatal intensive care beds and neonatal mortality.

10 o calculate the supply of neonatologists and neonatal intensive care beds in 246 neonatal intensive c

11 hether a greater supply of neonatologists or neonatal intensive care beds is associated with lower ne

12 etween the supply of both neonatologists and neonatal intensive care beds per capita (in quintiles) a

13 Despite recent advances in neonatal intensive care, CDH still has a high mortality

14 s of the European Society for Paediatric and Neonatal Intensive Care; four experts of the European So

15 Neonatal intensive care has been highly effective at imp

16 re in 1998-99, and shown how mortality after neonatal intensive care has fallen in the past 12 years.

17 ritical care services, similar to trauma and neonatal intensive care, has been suggested.

18 Existing studies of neonatal intensive care have focused on specific subsets

19 han 1500 g) born during the initial years of neonatal intensive care have now reached young adulthood

20 Cost-effective adaptations for neonatal intensive care, improved health-care funding, c

21 from a UK-wide sample of infants admitted to neonatal intensive care in 1998-99, and shown how mortal

22 port personnel in 32 (62.7%), and absence of neonatal intensive care in 29 (56.9%).

23 , which raises the possibility of overuse of neonatal intensive care in some newborns.

24 ed regional variation in the availability of neonatal intensive care in the United States.

25 ne in tandem with national audit systems for neonatal intensive care, incorporating measures of morbi

26 lid and simple method of risk-adjustment for neonatal intensive care is important to ensure accurate

27 risk of complications including admission to neonatal intensive care, macrosomia, low Apgar scores, a

28 t appears to have wide-spread application in neonatal intensive care nurseries where the babies' own

29 Recent neonatal intensive care outcome studies are asking more

30 ists and neonatal intensive care beds in 246 neonatal intensive care regions.

31 ons in the United States may have inadequate neonatal intensive care resources, whereas many others m

32 As neonatal intensive care services in middle-income develo

33 middle-income countries that have introduced neonatal intensive-care services for preterm and low-bir

34 In modern neonatal intensive care settings, ophthalmologic problem

35 : macrosomia, low birth weight, admission to neonatal intensive care/special care baby unit, and peri

36 ugh red blood cells (RBCs) are lifesaving in neonatal intensive care, transfusing older RBCs may resu

37 s previously been shown to increase risk for neonatal intensive care treatment, but otherwise the ass

38 rcent and 6 percent); who were admitted to a neonatal intensive care unit (6 percent and 7 percent);

39 ycemia, newborn sepsis, and admission to the neonatal intensive care unit (ICU).

40 < .0001); and those with intensive care unit/neonatal intensive care unit (ICU/NICU) admissions (OR =

41 nates (moderate evidence), or admission to a neonatal intensive care unit (low evidence).

42 The primary outcomes were prematurity, neonatal intensive care unit (NICU) admission, congenita

43 ek at delivery, birth weight, resuscitation, neonatal intensive care unit (NICU) admission, NICU leng

44 between fetal exposure to oral pathogens and neonatal intensive care unit (NICU) admission.

45 mple of children who were hospital ized in a neonatal intensive care unit (NICU) after birth.

46 xposed to multiple painful procedures in the neonatal intensive care unit (NICU) during a period of r

47 e if modifications to the preterm gut on the neonatal intensive care unit (NICU) impacted the gut mic

48 emely low-birth-weight (ELBW) infants in the neonatal intensive care unit (NICU) is associated with a

49 a greater effect on mortality risk than does neonatal intensive care unit (NICU) level.

50 trointestinal tracts of infants and from the neonatal intensive care unit (NICU) room environment.

51 We analyzed the relation between neonatal intensive care unit (NICU) strategies concernin

52 ty-four of these babies were admitted to the neonatal intensive care unit (NICU), and one of them had

53 mall-footprint, 1.5-T MRI scanner within our neonatal intensive care unit (NICU), diagnostic-quality

54 parents voice their dissatisfaction with the neonatal intensive care unit (NICU), it is often not bec

55 SA) is a frequent source of infection in the neonatal intensive care unit (NICU), often associated wi

56 tal of 266 infants in a single institutional neonatal intensive care unit (NICU), whose gestational a

57 s were acquired in nonsedated infants in the neonatal intensive care unit (NICU).

58 is (PFGE) typing to analyze an outbreak in a neonatal intensive care unit (NICU).

59 y; small for gestational age (SGA); need for neonatal intensive care unit (NICU); new onset of hypert

60 infancy, cesarean delivery, breast-feeding, neonatal intensive care unit [NICU] admission, and absen

61 el thrombosis and bleeding, and death in the neonatal intensive care unit [NICU]) after the first 50

62 higher rates of low birth weight (30.8%) and neonatal intensive care unit admission (30.8%) among neo

63 ed with glyburide were at increased risk for neonatal intensive care unit admission (RR = 1.41; 95% C

64 tress syndrome (RR = 6.5, 99% CI: 5.9, 7.1), neonatal intensive care unit admission (RR = 3.4, 99% CI

65 natal information and assessments during the neonatal intensive care unit admission and longitudinal

66 (2) Delayed intubation, (3) Normothermia on Neonatal Intensive Care Unit Admission, (4) Use of a pre

67 glyburide was 2.97% (95% CI, 1.82-4.12) for neonatal intensive care unit admission, 1.41% (95% CI, 0

68 Ten neonates required neonatal intensive care unit admission, five for respira

69 orn hospital stay, and 3.6 times the risk of neonatal intensive care unit admission.

70 e for gestational age, low birth weight, and neonatal intensive care unit admission.

71 ntilation and respiratory support during the neonatal intensive care unit admission.

72 weeks]) with various stages of ROP: 3 in the neonatal intensive care unit and 1 in the operating room

73 is of prematurity requiring admission to the neonatal intensive care unit and asthma.

74 ical center among 4 neonates with ROP in the neonatal intensive care unit and in the operating room.

75 Nurses are principal caregivers in the neonatal intensive care unit and support mothers to esta

76 justing after an infant's discharge from the neonatal intensive care unit and support the positive ps

77 Parents of infants hospitalized in the neonatal intensive care unit are routinely taught cardio

78 udy is an observational study in the level 3 neonatal intensive care unit at Parkland Hospital, Dalla

79 children were recruited as infants from the Neonatal Intensive Care Unit at Queen Charlotte's and Ha

80 (<30 weeks' gestational age; admitted to the neonatal intensive care unit at the Royal Women's Hospit

81 t 22 or 23 weeks of gestation at a level III neonatal intensive care unit at the University of Cologn

82 health care worker inadvertently exposed 32 neonatal intensive care unit babies to 2009 influenza A

83 During an outbreak of MRSA in a neonatal intensive care unit between July 18, 1991 and J

84 ll antibiotic use in infants admitted to the neonatal intensive care unit between March 1, 2012, and

85 tibiotic stewardship strategies in a level 3 neonatal intensive care unit by surveillance and assessm

86 gh assessment of antibiotic consumption in a neonatal intensive care unit can inform high-yield stewa

87 atal intensive care unit length of stay, and neonatal intensive care unit complications.

88 stillbirth, perinatal death, or admission to neonatal intensive care unit did not differ between wome

89 etected in specimens from six infants in our neonatal intensive care unit due to phenotypic character

90 sion to the Palomar Rady Children's Hospital Neonatal Intensive Care Unit during the 35 month study p

91 2502 infants were admitted to the neonatal intensive care unit during the two study period

92 racic Surgery, Pediatric Intensive Care, and Neonatal Intensive Care Unit Follow-Up teams to provide

93 ate recovery was associated with a stay in a neonatal intensive care unit for >28 days (P = 0.039), v

94 gh March 2012, we surveyed 272 babies in our neonatal intensive care unit for rectal colonization wit

95 weight <or=1.5kg admitted to a tertiary care neonatal intensive care unit from 2002 to 2006 were retr

96 Twenty-eight of 56 infants in a neonatal intensive care unit had stools positive for ade

97 ies) guidelines at a tertiary level academic neonatal intensive care unit in 2014.

98 erobacter sakazakii infections occurred in a neonatal intensive care unit in France from 5 May to 11

99 ion in the health and development of preterm/neonatal intensive care unit infants.

100 trition in health and development of preterm/neonatal intensive care unit infants.

101 Exposure to stressors in the Neonatal Intensive Care Unit is associated with regional

102 ase or mitigate exposure to stressors in the neonatal intensive care unit is warranted.

103 Of 13 neonatal intensive care unit isolates tested, all were m

104 The median neonatal intensive care unit length of stay was 34 days

105 mission to the neonatal intensive care unit, neonatal intensive care unit length of stay, and neonata

106 were higher and the odds for admission to a neonatal intensive care unit lower with planned out-of-h

107 We hypothesized that neonatal intensive care unit managerial practices and or

108 ith a structured neurobehavioral assessment (Neonatal Intensive Care Unit Network Neurobehavioral Sca

109 group had the least favorable scores on the Neonatal Intensive Care Unit Network Neurobehavioral Sca

110 of prematurely born infants were obtained by neonatal intensive care unit nurses.

111 inborn babies with type 1 zone 1 ROP at the Neonatal Intensive Care Unit of the Catholic University,

112 hough severe outcomes such as admission to a neonatal intensive care unit or perinatal mortality show

113 ic potential and 20% of thrombocytopenias in neonatal intensive care unit patients are severe.

114 gnificant morbidity and late mortality among neonatal intensive care unit patients.

115 Recent pilot randomized trials in the neonatal intensive care unit population have assessed th

116 ome was measured within the entire period of neonatal intensive care unit stay up to 90 days after ra

117 with or without fundoplication during their neonatal intensive care unit stay.

118 c P. aeruginosa infection among infants in a neonatal intensive care unit that was associated with ca

119 isk factors, neurodevelopmental follow-up of neonatal intensive care unit trials offers the potential

120 with neurological impairment admitted to the neonatal intensive care unit underwent GT placement alon

121 Cardiac arrests occurring in the neonatal intensive care unit were excluded.

122 less than 29 weeks who were admitted to the neonatal intensive care unit were prospectively studied

123 ial was conducted in infants admitted to the neonatal intensive care unit who weighed less than 1000

124 All neonates admitted to the neonatal intensive care unit with signs of respiratory d

125 Prospectively collected clinical data in the neonatal intensive care unit's medical database, nutriti

126 holucent lesion on an ultrasound scan in the neonatal intensive care unit, and cerebral palsy, microc

127 rrests occurring in the delivery department, neonatal intensive care unit, and in the out-of-hospital

128 Apgar scores, admission to the neonatal intensive care unit, and perinatal mortality we

129 microbiologically constrained ecosphere of a neonatal intensive care unit, gut bacterial communities

130 tential factor, exposure to stressors in the neonatal intensive care unit, has not yet been studied i

131 al mortality, fetal deaths, admission to the neonatal intensive care unit, neonatal intensive care un

132 Infants hospitalized in the neonatal intensive care unit, particularly preterm infan

133 h gentamicin at the time of admission to the neonatal intensive care unit, using a standard protocol,

134 d prematurity that required admission to the neonatal intensive care unit.

135 e investigated a putative MRSA outbreak in a neonatal intensive care unit.

136 reduce the rates of nosocomial sepsis in the neonatal intensive care unit.

137 n 8-month retrospective investigation in our neonatal intensive care unit.

138 cant cause of morbidity and mortality in the neonatal intensive care unit.

139 was significantly higher in neonates in the neonatal intensive care unit.

140 al sepsis, or admission of the infant to the neonatal intensive care unit.

141 ontact isolation during the outbreak in this neonatal intensive care unit.

142 clinical noninferiority trial at a tertiary neonatal intensive care unit.

143 Antibiotics are used frequently in the neonatal intensive care unit.

144 Observational cohort study in a level III neonatal intensive care unit.

145 gestational age, and hospitalization in the neonatal intensive care unit.

146 for gestational age (SGA) baby; need for the neonatal intensive care unit; doubling of serum creatini

147 cted age, all children were scheduled in the Neonatal Intensive-Care Unit Follow-Up Clinic for a visi

148 ive care units (15.5%, 95% CI 11.6-20.3) and neonatal intensive care units (10.7%, 9.0-12.7).

149 onducted from January 2010 to June 2013 at 3 neonatal intensive care units (2 academically affiliated

150 ital care workers (HCWs) in the surgical and neonatal intensive care units (ICUs) of four hospitals.

151 ts born in the United States are admitted to neonatal intensive care units (NICU) annually.

152 enter cohort study of 156 ELBW infants at 16 neonatal intensive care units (NICU) within the NICHD Ne

153 rugs in a cohort of neonates admitted to 290 neonatal intensive care units (NICUs) (the Pediatrix Dat

154 re born, and most spend their first weeks in neonatal intensive care units (NICUs) [1].

155 nence syndrome from 2004 through 2013 in 299 neonatal intensive care units (NICUs) across the United

156 Premature infants in neonatal intensive care units (NICUs) are highly suscept

157 CCC cases were reviewed from 2 academic neonatal intensive care units (NICUs) from 2004 to 2015.

158 To determine the proportion of neonatal intensive care units (NICUs) in 2014 that achie

159 been a large increase in both the number of neonatal intensive care units (NICUs) in community hospi

160 es were collected from infants nursed in two neonatal intensive care units (NICUs) in East London, Un

161 sion in the number of low-level and midlevel neonatal intensive care units (NICUs) in recent decades.

162 g less than 750 g at birth (N = 361) from 32 neonatal intensive care units (NICUs) in the United Stat

163 illin-resistant Staphylococcus aureus in the neonatal intensive care units (NICUs) of two hospitals.

164 bstantial shortfalls in nurse staffing in US neonatal intensive care units (NICUs) relative to nation

165 It is difficult for neonatal intensive care units (NICUs) to determine the o

166 lied SourceTracker to microbial surveys from neonatal intensive care units (NICUs), offices and molec

167 ors influencing azithromycin use in European neonatal intensive care units (NICUs).

168 se of morbidity and mortality in neonates in neonatal intensive care units (NICUs).

169 tly performed skin-breaking procedure in the neonatal intensive care units (NICUs).

170 o a loading-dose of phenobarbital from eight neonatal intensive care units across Europe.

171 significant PDA was conducted at 3 tertiary neonatal intensive care units and affiliated follow-up p

172 However, most infants at modern neonatal intensive care units are predominantly fed with

173 from June 29, 2011, to October 14, 2014, in neonatal intensive care units at 8 academic institutions

174 The setting was neonatal intensive care units at The Children's Hospital

175 esistant Staphylococcus aureus (MRSA) in the neonatal intensive care units at two hospitals, we asses

176 born in 558 Vermont Oxford Network hospital neonatal intensive care units between January 1, 2007, a

177 VLBW infants (<1500 g) admitted to level III neonatal intensive care units between January 1, 2010, a

178 o 29 participating Canadian Neonatal Network neonatal intensive care units between January 1, 2010, a

179 than 1250 g admitted to 6 Canadian tertiary neonatal intensive care units between May 2006 and June

180 A quarter of all neonates admitted to neonatal intensive care units develop thrombocytopenia,

181 term) of gestational age, were maintained in neonatal intensive care units for </=14 d.

182 Images were obtained from 13 North American neonatal intensive care units from eyes of infants with

183 All neonates admitted to 24 participating neonatal intensive care units from four countries (Austr

184 nfants with birth weight less than 1251 g in neonatal intensive care units in 13 North American cente

185 between January 2006 and December 2013 from neonatal intensive care units in 25 US children's hospit

186 al ophthalmologists participating in level 3 neonatal intensive care units in academic centers with i

187 days of birth, were enrolled at 3 level III neonatal intensive care units in Atlanta, Georgia.

188 onal cohort study in pediatric, cardiac, and neonatal intensive care units in eight hospitals, carrie

189 29 weeks of gestation and hospitalized in 68 neonatal intensive care units in France from April throu

190 33) were linked with structural data from 66 neonatal intensive care units in Germany.

191 5, 2009, and March 25, 2012, in 13 level III neonatal intensive care units in Germany.

192 intestinal food allergy was conducted in 126 neonatal intensive care units in Japan between April 201

193 ts (birth weight <1500 g) admitted to 1 of 6 neonatal intensive care units in the Netherlands from Ma

194 Louis with clinical data from the four neonatal intensive care units in the St.

195 1 hospitalized VLBW (<1500 g) infants at 348 neonatal intensive care units in the United States from

196 andomized clinical study was conducted at 16 neonatal intensive care units in the United States, with

197 low birth weight children from six regional neonatal intensive care units in Wisconsin and Iowa who

198 e hospital discharge of premature infants in neonatal intensive care units is often delayed due to th

199 ween 401 and 1000 g who were cared for in US neonatal intensive care units managed by the Pediatrix M

200 rge, nationally representative cohort at 348 neonatal intensive care units managed by the Pediatrix M

201 Twenty-two academic neonatal intensive care units participated.

202 n between 2010 and 2011 who were admitted to neonatal intensive care units participating in the Canad

203 gh close to half of the newborns admitted to neonatal intensive care units receive treatment for "hyp

204 nization with P. aeruginosa among infants in neonatal intensive care units should be investigated by

205 ical and surgical wards to the pediatric and neonatal intensive care units that occurred during 370,5

206 hic Association and 1998 and 1999 surveys of neonatal intensive care units to calculate the supply of

207 ices as rated by healthcare professionals in neonatal intensive care units were associated with the d

208 ntra-abdominal infections hospitalized in 24 neonatal intensive care units were studied in an open-la

209 Neonatal intensive care units with better work environme

210 collected from 4 geographically independent neonatal intensive care units, over a 48-month period.

211 e become an increasingly frequent problem in neonatal intensive care units, particularly among extrem

212 rtery bypass graft, angioplasty, cardiac and neonatal intensive care units, positron emission tomogra

213 ndardized kit for the CD64 index was used in neonatal intensive care units, showing high sensitivity

214 In contrast, in infants admitted to neonatal intensive care units, thrombocytopenia develops

215 Retrospective cohort study at tertiary neonatal intensive care units.

216 d for more than 48 h admitted to two level 3 neonatal intensive care units.

217 inical trial performed at 33 US and Canadian neonatal intensive care units.

218 (VLBW) infants varies widely among different neonatal intensive care units.

219 yndrome and has become a standard of care in neonatal intensive care units.

220 ation in approaches to oxygen therapy within neonatal intensive care units.

221 hs 500-1499 g, and we assessed this in eight neonatal intensive care units.

222 icarbonate therapy is used routinely in many neonatal intensive care units.

223 in the preterm and term infants admitted to neonatal intensive care units.

224 ommonly critically ill patients in adult and neonatal intensive care units.

225 conducted between 2008 and 2014 in 21 French neonatal intensive care units.

226 ere obtained during routine ROP screening in neonatal intensive care units.

227 ty are still low and vary considerably among neonatal intensive care units.

228 nificant cause of morbidity and mortality in neonatal intensive care units.

229 SI; (4) management of staphylococcal BSIs in neonatal intensive care units; and (5) defining the impa

230 UK recommendations suggest that large neonatal intensive-care units (NICUs) have better outcom

231 res of quality to explain overall quality of neonatal intensive care was modest.